Inventor · disambiguated record
Vibha Oza
Also filed as: OZA VIBHA · OZA VIBHA B
3 granted patents·10 pending applications·3 citations·filing 2002–2022
55Inventor score
Top patents by PatentIndex Score
13 records- 0179US11325903B2Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseasesBANTAM PHARMACEUTICAL LLC·Filed 2017·Granted May 10, 2022·2 cites·24 claims
- 0264US2023076820A1Substituted Pyrazole Compounds and Methods of Using Them for Treatment of Hyperproliferative DiseasesBANTAM PHARMACEUTICAL LLC·Filed 2022·Application pending·0 cites
- 0361US7423061B2Substitute thiophenes and uses thereofASTRAZENECA AB·Filed 2004·Granted Sep 9, 2008·1 cites·17 claims
- 0461US2009054396A1Substituted thiophenes and uses thereofASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 0546US2010029643A1Heterocyclyc sulfonamides having edg-1 antagonistic activityASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0645US2003045680A1Peptidic modulators of the androgen receptorPRAECIS PHARM INC·Filed 2002·Application pending·0 cites
- 0744US2009111860A1Sulfonamide compounds useful as adg receptor modulatorsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0843US2009105324A1Imidazole derivatives for use as edg-1 antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0942US12150934B2Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseasesBANTAM PHARMACEUTICAL LLC·Filed 2017·Granted Nov 26, 2024·0 cites·31 claims
- 1042US2010197749A1Chemical compoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1142US2007149560A1Novel fused triazolones and the uses thereofASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1239US2009233928A1Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferationANDREWS DAVID·Filed 2006·Application pending·0 cites
- 1332US2010317593A12,3-dihydro-1h-indene compoundsASTRAZENECA AB·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →